|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-1-22
|
|
pubmed:abstractText |
The purpose of this study was to test the safety and efficacy of pioglitazone and simvastatin in combination versus each drug individually in non-diabetic subjects with cardiovascular disease (CVD) and elevated high-sensitivity C-reactive protein (hs-CRP) levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
23
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
290-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17239709-Adult,
pubmed-meshheading:17239709-Aged,
pubmed-meshheading:17239709-C-Reactive Protein,
pubmed-meshheading:17239709-Cardiovascular Diseases,
pubmed-meshheading:17239709-Confidence Intervals,
pubmed-meshheading:17239709-Dose-Response Relationship, Drug,
pubmed-meshheading:17239709-Double-Blind Method,
pubmed-meshheading:17239709-Drug Administration Schedule,
pubmed-meshheading:17239709-Drug Therapy, Combination,
pubmed-meshheading:17239709-Female,
pubmed-meshheading:17239709-Follow-Up Studies,
pubmed-meshheading:17239709-Humans,
pubmed-meshheading:17239709-Inflammation Mediators,
pubmed-meshheading:17239709-Male,
pubmed-meshheading:17239709-Middle Aged,
pubmed-meshheading:17239709-Probability,
pubmed-meshheading:17239709-Prospective Studies,
pubmed-meshheading:17239709-Risk Assessment,
pubmed-meshheading:17239709-Severity of Illness Index,
pubmed-meshheading:17239709-Simvastatin,
pubmed-meshheading:17239709-Thiazolidinediones,
pubmed-meshheading:17239709-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
|
|
pubmed:affiliation |
GWT, Center for Clinical Studies, Dresden, Germany. hanefeld@gwtonline-zks.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
